What we do

Create state-of-the-art saliva testing to provide users a deep understanding of their biology, enabling them and their healthcare providers to make data-informed decisions that improve their mental and physical well-being.

The company behind obi

Orthogonal Diagnostics Inc., founded in 2012 by Dr. David Charlton, the inventor of lateral flow technology, has established itself as a pioneer in the development of saliva-based diagnostics. The oversight and leadership members comprise over 90 years of diagnostic development experience and have been inventors on multiple patents—most notably the Charlton Patent—and several patents for obi.

With a profound commitment to innovation, Orthogonal’s team of seasoned experts, including Andrew Charlton (CEO) and Dr. David Charlton (CSO), drive its mission forward. They leverage their extensive experience to pioneer consumer health monitoring technologies that offer unprecedented access to vital health data. Orthogonal’s focus on saliva testing merges scientific rigor with market insights gained from real world experience, setting new benchmarks for accessibility and reliability for the health & wellness industry.

Team bios